223 related articles for article (PubMed ID: 33413309)
21. Tc-99m red blood cell uptake in positive somatostatin receptor scintigraphy by two accessory spleens.
Martínez-Rodríguez I; Allende RH; Banzo I; Quirce R; Jiménez-Bonilla J; Sainz-Esteban A; Carril JM
Clin Nucl Med; 2006 Jun; 31(6):340-1. PubMed ID: 16714895
[No Abstract] [Full Text] [Related]
22. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
Kunikowska J; Lewington V; Krolicki L
Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
[TBL] [Abstract][Full Text] [Related]
23. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.
Nockel P; Babic B; Millo C; Herscovitch P; Patel D; Nilubol N; Sadowski SM; Cochran C; Gorden P; Kebebew E
J Clin Endocrinol Metab; 2017 Jan; 102(1):195-199. PubMed ID: 27805844
[TBL] [Abstract][Full Text] [Related]
24. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
[TBL] [Abstract][Full Text] [Related]
25. Ectopic insulinoma diagnosed by 68Ga-Exendin-4 PET/CT: A case report and review of literature.
Zhang X; Jia H; Li F; Fang C; Zhen J; He Q; Liu M
Medicine (Baltimore); 2021 Apr; 100(13):e25076. PubMed ID: 33787590
[TBL] [Abstract][Full Text] [Related]
26. Ectopic insulinoma: case report.
Sun M; Luo Y; You Y; Han X; Zhao Y; Han X; Zhao Y
BMC Surg; 2019 Dec; 19(1):197. PubMed ID: 31852474
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
Jois B; Asopa R; Basu S
Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
[TBL] [Abstract][Full Text] [Related]
28. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
29. Case report of tc-99m sulfur colloid single-photon emission computed tomography/computed tomography study differentiating tumor from accessory spleen.
Aggarwal R; Wagner T; Navalkissoor S
World J Nucl Med; 2013 Sep; 12(3):129-31. PubMed ID: 25165426
[TBL] [Abstract][Full Text] [Related]
30. Intrapancreatic Accessory Spleen Mimicking Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT.
Bhure U; Metzger J; Keller FA; Zander A; Lago MP; Herring K; Strobel K
Clin Nucl Med; 2015 Sep; 40(9):744-5. PubMed ID: 26053721
[TBL] [Abstract][Full Text] [Related]
31. Intrapancreatic accessory spleen mimicking malignant tumor: three case reports.
Zurek Munk-Madsen M; Zakarian K; Sandor Oturai P; Hansen CP; Federspiel B; Fallentin E; Linno Willemoe G
Acta Radiol Open; 2019 Jun; 8(6):2058460119859347. PubMed ID: 31285851
[TBL] [Abstract][Full Text] [Related]
32. [Intermittent disturbances of perception during fasting in a 46-year-old female patient].
Ravens S; Scheit L
Internist (Berl); 2020 Sep; 61(9):964-968. PubMed ID: 32734334
[TBL] [Abstract][Full Text] [Related]
33. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
34. Heat-Damaged Red Blood Cell Scintigraphy in Helping Interpretation of 68Ga-DOTATATE PET/CT.
Wen Z; Edwards KW; States LJ; Zhuang H
Clin Nucl Med; 2019 Nov; 44(11):927-928. PubMed ID: 31306208
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumor detected by technetium-99m methoxy-2-isobutylisonitrile single photon emission computed tomography/computed tomography: A case report.
Liu CJ; Yang HJ; Peng YC; Huang DY
World J Clin Cases; 2023 Apr; 11(12):2825-2831. PubMed ID: 37214577
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of Splenic Scintigraphy in Differentiating Splenosis and Malignancy on Gallium 68 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-NaI3-octreotide.
Van Hecke S; Wyngaert TVD; De Beeck BO; Stroobants S
World J Nucl Med; 2018; 17(1):56-58. PubMed ID: 29398968
[TBL] [Abstract][Full Text] [Related]
38. Preparation and labelling of red blood cells with [
Drescher R; Gröber S; Freesmeyer M; Greiser J
Nucl Med Biol; 2023; 118-119():108333. PubMed ID: 36940567
[TBL] [Abstract][Full Text] [Related]
39. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
